PAHC · Phibro Animal Health Corp
$33.88
-0.48 (-1.40%)
At close · Aug 17
Market Cap
$1.39B
Shares
40.56M
Phibro Animal Health Corp Earnings Call Transcripts
Every quarterly earnings call for Phibro Animal Health Corp (PAHC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲15.9%
$255.26M
$7.49M
'22 Q4
22-08-25
▲8.3%
$232.52M
$3.86M
'23 Q1
22-11-10
▲5.1%
$244.65M
$7.21M
'23 Q2
23-02-08
▲2.5%
$245.67M
$10.04M
'23 Q3
23-05-04
▼0.1%
$255.05M
$11.50M
'23 Q4
23-08-31
▼0.5%
$231.35M
−$8.02M
'24 Q1
23-11-09
▲2.2%
$249.94M
$1.27M
'24 Q2
24-02-07
▲7.1%
$263.22M
$8.40M
'24 Q3
24-05-09
▲7.1%
$273.16M
$752,000
'24 Q4
24-08-29
▲12.6%
$260.43M
$6.97M
'25 Q1
24-11-07
▲23.7%
$309.26M
$3.19M
'25 Q2
25-02-05
▲32.1%
$347.82M
$20.88M
'25 Q3
25-05-08
▲38.6%
$378.70M
$17.22M
'25 Q4
25-08-28
▲39.7%
$363.89M
$26.53M
'26 Q1
25-11-06
▲20.9%
$373.91M
$27.46M
'26 Q2
26-02-05
LATEST
▲10.3%
$383.54M
$24.02M
'26 Q3
26-05-07
Conference
Investor event
2026-05-27
Stifel Jaws & Paws Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-05-07
Phibro Animal Health Corp Q3 FY2026 Earnings Call
Confident tone
Updated fiscal 2026 guidance
Brazil antimicrobial regulatory change
Animal health segment performance
Revenue
$383.54M
▲ 10.3% YoY Diluted EPS
$0.59
▲ 15.7% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-02-05
Phibro Animal Health Corp Q2 FY2026 Earnings Call
Confident tone
Animal health segment growth and MFA integration
Phibro Forward cost and margin initiatives
Raised full-year guidance
Revenue
$373.91M
▲ 20.9% YoY Diluted EPS
$0.67
▲ 737.5% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-11-06
Phibro Animal Health Corp Q1 FY2026 Earnings Call
Confident tone
Animal Health Segment Growth
Full-Year Guidance Raise
Legacy Business & Quarterly Mix
Revenue
$363.89M
▲ 39.7% YoY Diluted EPS
$0.65
▲ 282.4% YoY Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-08-28
Phibro Animal Health Corp Q4 FY2025 Earnings Call
Confident tone
FY2026 Guidance
Zoetis MFA Acquisition / Integration
Animal Health Segment Growth
Revenue
$378.70M*
▲ 38.6% YoY Gross margin
29.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-05-08
Phibro Animal Health Corp Q3 FY2025 Earnings Call
Confident tone
Guidance update and outlook
Tariffs and supply chain mitigation
Lobbying for animal health tariff exceptions and FX
Revenue
$347.82M
▲ 32.1% YoY Diluted EPS
$0.51
▲ 142.9% YoY Gross margin
30.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-02-05
Phibro Animal Health Corp Q2 FY2025 Earnings Call
Confident tone
Animal Health Segment Growth
Zoetis MFA Integration
Phibro Forward Initiative
Revenue
$309.26M
▲ 23.7% YoY Diluted EPS
$0.08
▲ 166.7% YoY Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-11-07
Phibro Animal Health Corp Q1 FY2025 Earnings Call
Confident tone
Zoetis Medicated Feed Additive acquisition
Strong organic growth and operating leverage
Acquisition transition and financial dilution
Revenue
$260.43M
▲ 12.6% YoY Diluted EPS
$0.17
Gross margin
32.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-08-29
Phibro Animal Health Corp Q4 FY2024 Earnings Call
Confident tone
Fiscal 2025 guidance
Animal Health segment growth
Mineral Nutrition and Performance Products
Revenue
$273.16M*
▲ 7.1% YoY Gross margin
31.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-05-09
Phibro Animal Health Corp Q3 FY2024 Earnings Call
Confident tone
Animal Health Segment Growth
FY2024 Financial Guidance
Zoetis MFA Acquisition
Revenue
$263.22M
▲ 7.1% YoY Diluted EPS
$0.21
▼ 16% YoY Gross margin
30.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-02-07
Phibro Animal Health Corp Q2 FY2024 Earnings Call
Positive tone
Vaccine growth
Guidance and outlook
Mineral Nutrition and Performance Products headwinds
Revenue
$249.94M
▲ 2.2% YoY Diluted EPS
$0.03
▼ 83.3% YoY Gross margin
31.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-11-09
Phibro Animal Health Corp Q1 FY2024 Earnings Call
Revenue
$231.35M
▼ 0.5% YoY Diluted EPS
$-0.20
▼ 300% YoY Gross margin
29.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-08-31
Phibro Animal Health Corp Q4 FY2023 Earnings Call
Revenue
$255.05M*
▼ 0.1% YoY Gross margin
30.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-05-04
Phibro Animal Health Corp Q3 FY2023 Earnings Call
Revenue
$245.67M
▲ 2.5% YoY Diluted EPS
$0.25
▼ 43.2% YoY Gross margin
30.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-02-08
Phibro Animal Health Corp Q2 FY2023 Earnings Call
Revenue
$244.65M
▲ 5.1% YoY Diluted EPS
$0.18
▼ 58.1% YoY Gross margin
31.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-11-10
Phibro Animal Health Corp Q1 FY2023 Earnings Call
Revenue
$232.52M
▲ 8.3% YoY Diluted EPS
$0.10
▼ 37.5% YoY Gross margin
29.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-08-25
Phibro Animal Health Corp Q4 FY2022 Earnings Call
Revenue
$255.26M*
▲ 15.9% YoY Gross margin
30.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-05-05
Phibro Animal Health Corp Q3 FY2022 Earnings Call
Revenue
$239.62M
▲ 13.2% YoY Diluted EPS
$0.44
▲ 46.7% YoY Gross margin
29.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-02-09
Phibro Animal Health Corp Q2 FY2022 Earnings Call
Revenue
$232.71M
▲ 12.9% YoY Diluted EPS
$0.43
▲ 34.4% YoY Gross margin
30.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-11-03
Phibro Animal Health Corp Q1 FY2022 Earnings Call
Revenue
$214.66M
▲ 10% YoY Diluted EPS
$0.16
▼ 46.7% YoY Gross margin
30.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-08-26
Phibro Animal Health Corp Q4 FY2021 Earnings Call
Revenue
$220.28M*
▲ 18.5% YoY Gross margin
31.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-05-07
Phibro Animal Health Corp Q3 FY2021 Earnings Call
Revenue
$211.73M
▲ 0.5% YoY Diluted EPS
$0.30
▼ 9.1% YoY Gross margin
32.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-02-03
Phibro Animal Health Corp Q2 FY2021 Earnings Call
Revenue
$206.15M
▼ 3.7% YoY Diluted EPS
$0.32
▲ 10.3% YoY Gross margin
33.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-11-05
Phibro Animal Health Corp Q1 FY2021 Earnings Call
Revenue
$195.19M
▲ 2.9% YoY Diluted EPS
$0.30
▲ 400% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-08-27
Phibro Animal Health Corp Q4 FY2020 Earnings Call
Revenue
$185.88M*
▼ 8.8% YoY Gross margin
32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-05-08
Phibro Animal Health Corp Q3 FY2020 Earnings Call
Revenue
$210.74M
▲ 2.4% YoY Diluted EPS
$0.33
▼ 10.8% YoY Gross margin
33.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-02-03
Phibro Animal Health Corp Q2 FY2020 Earnings Call
Revenue
$214.01M
▼ 1.9% YoY Diluted EPS
$0.29
▼ 19.4% YoY Gross margin
32.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts
CIK
1069899
CUSIP
71742Q106
13F (30d)
193 filings
190 filers
Visit website
Investor relations